CIM Investment Management’s Zimmer Biomet ZBH Stock Holding History

CIM Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$370K	Sell	4,095 -20	-0.5%	-$1.83K	0.1%	165
2025 Q4	$370K	Hold	4,115	–	–	0.1%	162
2025 Q3	$405K	Sell	4,115 -43	-1%	-$4.26K	0.11%	144
2025 Q2	$379K	Sell	4,158 -18	-0.4%	-$1.74K	0.07%	194
2025 Q1	$473K	Sell	4,176 -4	-0.1%	-$428	0.11%	121
2024 Q4	$442K	Buy	4,180 +19	+0.5%	+$2.04K	0.13%	131
2024 Q3	$449K	Sell	4,161 -75	-2%	-$8.19K	0.13%	132
2024 Q2	$460K	Sell	4,236 -25	-0.6%	-$2.95K	0.14%	132
2024 Q1	$562K	Hold	4,261	–	–	0.17%	118
2023 Q4	$519K	Hold	4,261	–	–	0.17%	124
2023 Q3	$478K	Sell	4,261 -103	-2%	-$13.1K	0.18%	120
2023 Q2	$635K	Buy	4,364 +11	+0.3%	+$1.5K	0.22%	99
2023 Q1	$562K	Buy	4,353 +215	+5%	+$27K	0.21%	107
2022 Q4	$528K	Sell	4,138 -118	-3%	-$13.7K	0.21%	106
2022 Q3	$445K	Hold	4,256	–	–	0.2%	111
2022 Q2	$447K	Sell	4,256 -24	-0.6%	-$2.85K	0.19%	115
2022 Q1	$547K	Sell	4,280 -134	-3%	-$16.2K	0.18%	112
2021 Q4	$544K	Sell	4,414 -87	-2%	-$11.4K	0.16%	132
2021 Q3	$640K	Sell	4,501 -27	-0.6%	-$3.97K	0.2%	103
2021 Q2	$707K	Sell	4,528 -25	-0.5%	-$4.05K	0.22%	94
2021 Q1	$708K	Sell	4,553 -178	-4%	-$27.6K	0.22%	85
2020 Q4	$708K	Sell	4,731 -78	-2%	-$11K	0.23%	82
2020 Q3	$636K	Sell	4,809 -53	-1%	-$6.92K	0.24%	87
2020 Q2	$563K	Hold	4,862	–	–	0.23%	97
2020 Q1	$477K	Sell	4,862 -521	-10%	-$68.3K	0.23%	94
2019 Q4	$782K	Hold	5,383	–	–	0.31%	70
2019 Q3	$717K	Sell	5,383 -526	-9%	-$67.9K	0.27%	66
2019 Q2	$675K	Buy	5,909 +3,215	+119%	+$377K	0.25%	84
2019 Q1	$334K	Hold	2,694	–	–	0.13%	219
2018 Q4	$271K	Sell	2,694 -109	-4%	-$12.3K	0.12%	232
2018 Q3	$358K	Sell	2,803 -1	-0%	-$119	0.13%	232
2018 Q2	$303K	Sell	2,804 -2,951	-51%	-$321K	0.1%	277
2018 Q1	$609K	Sell	5,755 -140	-2%	-$16.3K	0.21%	130
2017 Q4	$691K	Sell	5,895 -87	-1%	-$9.84K	0.24%	107
2017 Q3	$680K	Sell	5,982 -349	-6%	-$40.3K	0.25%	97
2017 Q2	$789K	Buy	6,331 +263	+4%	+$31.2K	0.28%	80
2017 Q1	$719K	Sell	6,068 -582	-9%	-$66K	0.25%	90
2016 Q4	$666K	Buy	6,650 +79	+1%	+$8.47K	0.24%	104
2016 Q3	$830K	Sell	6,571 -526	-7%	-$65K	0.32%	78
2016 Q2	$829K	Sell	7,097 -319	-4%	-$36.1K	0.34%	76
2016 Q1	$768K	Sell	7,416 -913	-11%	-$88.3K	0.33%	88
2015 Q4	$830K	Hold	8,329	–	–	0.38%	89
2015 Q3	$760K	Hold	8,329	–	–	0.37%	95
2015 Q2	$883K	Hold	8,329	–	–	0.39%	94
2015 Q1	$950K	Hold	8,329	–	–	0.41%	88
2014 Q4	$917K	Buy	+8,329	New	+$878K	0.42%	87

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIM Investment Management's ZBH Position: Q1 2026 in Review

CIM Investment Management reduced its Zimmer Biomet (ZBH) stake by 0.49% in Q1 2026, selling an estimated $1.83K and leaving 4,095 shares worth $370K. The position accounts for 0.1% of the portfolio, ranked #165.

CIM Investment Management first reported a position in ZBH in Q4 2014 and has held it in 46 quarters since. The position peaked at $950K in Q1 2015. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

CIM Investment Management held 4,095 shares of Zimmer Biomet worth $370K as of Q1 2026.
CIM Investment Management sold 20 Zimmer Biomet shares in Q1 2026, an estimated $1.83K.
Zimmer Biomet made up 0.1% of CIM Investment Management's portfolio in Q1 2026, its #165 holding.
CIM Investment Management first reported a position in Zimmer Biomet in Q4 2014 and has held it in 46 quarters since.
CIM Investment Management's Zimmer Biomet position peaked at $950K in Q1 2015.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on CIM Investment Management's 13F filing for Q1 2026, filed 19 May 2026.